Disclosures for "Effect of Selumetinib Treatment on Long-term Prescription Pain Medication Utilization in Adults: A Retrospective Study of a U.S. Claims Database"
-
Mrs. Lyons has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease.
-
Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
-
Ms. Dettling has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Ms. Dettling has stock in Alexion, AstraZeneca Rare Disease.
-
Ms. Bowling has received personal compensation for serving as an employee of AstraZeneca Rare Disease. Ms. Bowling has stock in AstraZeneca Rare Disease.
-
Mr. Anand has nothing to disclose.
-
Mr. Sicilia has received personal compensation for serving as an employee of Forian, Inc.
-
Dr. Meade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Meade has received personal compensation in the range of $0-$499 for serving as a Consultant for Adivo Associates.